Save the Date!
NLARx will host two panels at the July conference of the National Conference of State Legislators: "Do Trade Policies Threaten Access to Affordable Medicines in the States?" (July 21) and "Data, Drugs and Disclosure: States Lead the Way on Pharmaceutical Policy" (July 24) More
|
NLARx News
Supreme Court Declines to Hear Challenge to New Hampshire Prescription Privacy Act More
United States Court of Appeals for the First Circuit Refuses to Stay Implementation of Vermont Prescription Law More
Prescription Drug Model Bill to Limit Drug Industry Marketing Enacted in Vermont More
|
In the States
MASSACHUSETTS: Better Ethics, Cheaper Drugs More
VERMONT: U.S. Supreme Court Denies Bid to Limit State's Law on Prescription Data More
Attorney General Writes Senate Finance Committee in Support of the Sunshine Act More
|
Outrages of the Week
Ex-Pfizer Executive: Off-Label Promo 'Part Of Pfizer Culture' More
Matrixx Withheld 800 Complaints On Zicam More
|
Prices and Access to Healthcare
Pharma Pricing Deal Still Has Question Marks MoreCost Effectiveness Research: A Cost-Saving Myth MoreTreximet: Cautionary Tale Of Payer Price Revolt MoreLilly Erbitux Cancer Drug Not Worth Price, U.S. Scientists Say More |
Patents and Generics
Removing Obstacles to Generic Drug Competition More
FTC: Kill Pay-For-Deals Between Brand and Generic Producers, Save $35 Billion More
Supremes Won't Review Pay-For-Delay Case More
Obama Backs Seven Year Data Exclusivity For Generic Biologics More
One-Third Of Americans Don't Trust Generics More
White House: 7 Years Enough to Shield Biotech Drugs More
Emerging Markets Key In Generics, Too More
A U.S. Generics Shop Looks to India for Biotech More
|
Conflicts of Interest
Sen. Grassley Seeks Information About Medical School Policies for Disclosure of Financial Ties More
Med Schools Improve Conflict Of Interest Policies, But Widespread Problems Remain More
House Puts Sunshine Act in Health Reform Bill More
Transparency and Medtronic's $800,000 Doctor More
|
Advertising and Marketing
Drug Firms' Medical Staff Say What Sales Representatives Can't More
Drug Companies Increasingly Use Medical Science Liaisons to Promote Unapproved Drugs More
Pharma Ad Spend Falls; TV Takes Bigger Share More
Pfizer Exec: Company Approved of Off-Label Bextra Promotion More
Do Pharma Marketers Encourage Consumers To Self-Diagnose? More
Pharma Marketers Should Stop Blaming The FDA For Their Dysfunctional Social Media Marketing Efforts More
House Bill May Target Drugmakers' Advertising Tax Breaks More
|
Pharma Watch
Report: Health Industry Spends Upwards Of $1.4 Million A Day On Lobbyists More
Will Over a Million a Day Convince Congress to Buy Big
Pharma's Rx for Change? More
Biologics To Top Pharma Sales By 2014 More
Novartis Scores Big Hit on Small Market With Gene-Based Medicine More
Sanofi To Amp Up Generics Push, Cut R&D More
Sanofi CEO: Think Small In Big Pharma More
Pfizer Willing To Pay More For Wyeth More
Drugmakers Pledge $80 Billion To Health Reform More
The Drug Industry's Offer More
|
PBM Watch
Lawmakers Rip Federal Drug Plan Managers For Rising Costs More
FTC Competition Unit to Examine CVS Caremark More
Walgreens, Express Scripts Fight Over 'Blitzkrieg' Audits More
|
Medicare
Drug Makers Trim Medicare Part D Prices for Health Overhaul More
Splitting the Medicare Drug Benefit's Doughnut Hole More
Federal Saving From Lowering of Drug Prices Is Unclear More
PhRMA's Big Promise More
Pharma's Doughnut Deal Could Slow Seniors' Shift to Generics More
For Drug Makers, Medicare Part D Concessions Have a Bright Side More
AARP Wins One With Pharma Pledge on Medicare Doughnut Hole More
Massive Medicare Fraud Case Highlights Miami's Increased Enforcement More
Once Again, Washington Pledges to Fight Medicare Fraud More
|
Medicaid
15 U.S. States Say Wyeth Failed to Pay Medicaid Rebates MoreMore States Sue Wyeth Over Protonix Pricing MoreArguments in Medicaid Drug Pricing Lawsuit Begin in Alabama More |
Safety and Clinical Trials
Acetaminophen Worries: The End of NyQuil as We Know It? MoreStudy: Sanofi's Lantus Insulin Has Possible Cancer Link MoreStudy: Gardasil Not As Cost-Effective For Boys MoreDA Hears From All Sides On Info Sharing MoreFDA Warning Letters Stir More Questions Than Answers MoreNew FDA Commissioner Addresses Drug Regulation and FDA Challenges MoreCould Seroquel Liability Suits Be A Bust? More |
